A dilemma in healthcare research The pursuit of medical research and the continuing efforts to upgrade health care have transformed medicine into a vocation involving high technology which includes the vigorous development of methods of creating and preserving life. The life creating procedures like in vitro fertilization have revolutionized a particular area of therapeutic need and in so doing have caught the imagination of the public and the medial. Ethical considerations arising out of such procedures have become points of debate. The formulation of ethical guidelines and the institution of a legal body to monitor and regulate such modes of treatment will in turn become a stumbling block if further developments in research on human embryos are cutback or banned-". It has become necessary to weigh the priorities that have been given to research into, and practice of, those methods that create life artificially against those which are concerned with preserving existing human life. It is a matter requiring careful scrutiny by the international medical community.
How far should human endeavour in the form of human experimentation be allowed to seek new knowledge in order to preserve life? Life-preserving methods such as organ donation and transplantation have led to the introduction ofthe definition of 'brain death"! as equivalent to biological death, enabling some countries to allow certain procedures of organ procurement which require normally functioning circulatory and respiratory systems of the donor to be maintained artificially. Organ transplantation programmes have undoubtedly benefited from this change in the concept of death", One area which has gained in importance has concerned ways of reducing mortality among patients with acute myocardial infarction. There has been a three-pronged approach, namely to find the cause of thrombus formation, to salvage jeopardized myocardium and to develop thrombolytic drugs, and all leading to the conclusion that no form of medical intervention is likely to be as effective for preserving myocardial cells as by the restoration of blood flow to the obstructed artery", Coronary arterial thrombolytic therapy has been advocated to improve ventricular function with a view to reduce mortality in patients with early acute myocardial infarction. As myocardial necrosis is a rapidly progressing phenomenon, coronary thrombolysis will only be beneficial if reperfusion is accomplished swiftly and permanently. Most of the approved thrombolytic agents accomplish reperfusion but reocclusion of the vessel is frequent. To avoid such reocclusion administering a monoclonal antibody directed against platelet receptor GP IIb/lIIa has reported to be promising in animal studies as well as in a study conducted on a 'newmort' (newly dead person) recently. Such a study conducted on a newmort with an active circulatory system maintained by mechanical means has paved the way for conducting heamorheological studies. Studies on brain dead persons were predicted much earlier and was considered ethically acceptable provided adequate precautions were taken to maintain human dignity. This ethical acceptability may hold good in a secular and pluralistic society where the individual right to medical benefit reigns supreme, but acceptability of such a study on a newmort by different religions and possibly certain social structures may not be easy when manipulation of a dead body is considered to be a violation of religious principles and a transgression of social values", If the same observations were reported as being derived from the end ofthe treatment of a critically ill patient whose consent was taken for such a study it might have been welcomed as a life preserving research procedure. In other words, the terminology plays a vital role in decisions made to promote or to discard such methodologies, because the term 'medical research' cannot always be equated comfortably with 'life-saving procedures' or 'organ procurement'. The value of research on a newmort would also be judged on the basis whether such a therapy will reach all those who need it; it is already felt that healthcare is distributed inequitably in our society.
Research is the driving force and nourishing source of medical care. What type of research could be pursued under what conditions, and how far can one pursue such research with humans, alive or dead, are matters of wide ethical concern including the resolution of moral issues through mutual respect of personal and cultural sensitivities free from dictation, pressure or any form of coercion. Such checks and moral introspection will enable medicine to respond positively to such challenging remarks as:
'What rights do the medical personnel have, in the absence of an agreed moral basis, to force their insights into other people'.
